Addiction Treatment Market

Global Addiction Treatment Market Size

The global addiction treatment market was worth US$ 11.24 billion in 2025 and is anticipated to reach a valuation of US$ 19.12 billion by 2034, from US$ 11.92 billion in 2026, and it is predicted to register a CAGR of 6.08% during the forecast period (2026 to 2034).

Addiction refers to the state of being unable to refuse the consumption of a particular substance. Addiction usually occurs with prescription drugs, heroin, alcohol, cannabis, cocaine, and amphetamines. These are called psychoactive drugs, which stimulate the nervous system and give the consumer a world kind of experience and state of euphoria, which causes addiction in the consumers. Addiction provokes repeated use of substances that are derogatory to the body. It is a mental disorder; it makes people consume substances even while knowing it is harmful to their bodies. Addiction is a psychological condition that is treated in various ways. The purpose of addiction treatment is to stop patients' compulsive substance abuse habits and induce self-control. Addiction can occur for multiple reasons and can lead to chronic diseases in individuals. For example, cigarette smoking has helped increase the number of cases of lung cancer, and tobacco consumption kills around 8 million people annually. Therefore, as the situation becomes adverse, there is a rising need for addiction treatment. The addiction treatment market works around the various substances and institutions and ways addiction is cured.

MARKET DRIVERS

Rising product approvals and launches, de-addiction programs from numerous organizations, and the increasing prevalence of dependency on psychoactive drugs such as alcohol, opioid, tobacco, cocaine, heroin, marijuana, and others are majorly propelling the global addiction treatment market.

Additionally, following the increasing number of nicotine addiction cases, public and private groups are working to raise knowledge about nicotine de-addiction, which helps smokers who are addicted to stop smoking and aids cessation. For instance, to raise awareness about quitting smoking, Public Health England conducted a US$ 1.3 million smoking cessation campaign in 2017.

Acquisitions and mergers to promote the addiction treatment market growth.

To enhance their market presence, leading players active in the market for addiction treatment are concentrating on adopting inorganic development tactics, including acquisitions, mergers, partnerships, and collaborations. For instance, the recently approved methadone hydrochloride 5 mg and 10 mg tablets from Elite Laboratories Inc., a specialty pharmaceutical business, were distributed by Glenmark Pharmaceuticals Ltd., a major integrated research-based, worldwide pharmaceutical corporation. According to the agreement, Elite will get a manufacturing license for methadone, and Glenmark Pharmaceuticals, Inc. will sell and distribute methadone for Elite in the United States.

MARKET RESTRAINTS

However, factors such as hesitance and noncompliance of addicted patients to join the treatment facility, along with withdrawal and relapse of patients during treatment, can prove to be a drawback to the growth of the global addiction treatment market.

REPORT COVERAGE

SEGMENTAL ANALYSIS

By Treatment Type Insights

Based on treatment type, the nicotine addiction segment is expected to show rapid growth during the forecast period due to the rise in tobacco consumption as cigarettes around the world. In addition, the accessibility and availability of nicotine replacement drugs like transdermal patches, oral sprays, nicotine gum, etc., help the market grow.

By Drug Type Insights

Due to an increase in product introductions, the sector for nicotine replacement therapies is estimated to hold the most significant share of the global addiction treatment market during the forecast period. The methadone segment is also estimated to contribute to the growth as a generic version of Dolophine, methadone hydrochloride tablets, USP in strengths of 5 mg and 10 mg, was introduced by the generic pharmaceutical company Epic Pharma, LLC in the recent period. The management of pain indication and the treatment of opioid addiction is indicated for methadone hydrochloride tablets, thus increasing the demand for the tablets.

By Treatment Centre Insights

The inpatient category is the most common type of rehab for drug addicts and is expected to continue growing during the forecast period. Inpatient refers to the patients who stay in centers and are continuously monitored and treated.

By Distribution Channel Insights

Based on the distribution channel, the hospital pharmacies segment is the most common distribution channel in the addiction treatment market. Factors such as increased awareness of drug side effects and faster detection and treatment of individuals in hospitals with the option of admitting patients in critical conditions contribute to the segment's growth.

REGIONAL ANALYSIS

North America Addiction Treatment Market Analysis

Geographically, North America is projected to hold the largest share of the global addiction treatment market during the forecast period due to rising illicit drug use, an increase in the number of smokers, and growing concerns about health problems for both active and passive smokers. Furthermore, with the developments of addiction treatment in countries like the U.S. and Canada, with high addiction rates, the region is anticipated to record a significant share in the market. In addition, the development of the healthcare sector and the legalization of marijuana are expected to spur market expansion.

Europe Addiction Treatment Market Analysis

Europe is anticipated to witness a prominent share in the global addiction treatment market during the forecast period. However, due to a rise in the consumption of tobacco products and alcohol addiction in this region. In countries like the U.K., which have approximately 3.2 million people who have taken a drug according to 2018-19 stats, and other countries like Germany, Italy, France, etc., the market in the region is progressing.

Asia-Pacific Addiction Treatment Market Analysis

Due to rising medical tourism, declining therapy costs, and an increase in tobacco users and smokers, the Asia-Pacific will experience a very high growth rate. This growth is also due to a significant increase in therapeutic facilities and ongoing government initiatives to raise public awareness of addiction in countries like India, China, Japan, South Korea, etc.

KEY MARKET PLAYERS

The leading companies operating in the global addiction treatment market include:

• Pfizer Inc.
• Mallinckrodt
• Orexo AB
• Indivor Plc
• Teva Pharmaceutical Industries Ltd
• GlaxoSmithKline Plc
• Cipla Ltd.
• Alkermes Plc
• Hikma Pharmaceuticals PLC
• Titan Pharmaceuticals, Inc.
• Dr. Reddy's Laboratories Limited
• Perrigo Company Plc
• Mylan N.V.

GLOBAL ADDICTION TREATMENT MARKET NEWS

• On June 13th, 2022, the Bringham and Women's hospital researchers identified a brain circuit that can be targeted to treat addiction. The researchers use brain lesion mapping to map out the brain circuits and imply addiction remission to them.
• On June 10th, 2022, it was announced that boulder care, a startup company from Portland that uses telehealth to treat people with addiction, raised $36 million to develop better telehealth care.

MARKET SEGMENTATION

This research report on the global addiction treatment market has been segmented and sub-segmented based on the treatment type, drug type, treatment center, distribution channel, and region.

By Treatment Type

• Tobacco/Nicotine Addiction Treatment
• Opioid Addiction Treatment
• Alcohol Addiction Treatment
• Other Substance Addiction Treatment

By Drug Type

• Bupropion
• Varenicline
• Acamprosate
• Buprenorphine
• Disulfiram
• Methadone
• Naltrexone
• Nicotine Replacement Products
• Others

By Treatment Centre

• Outpatient Treatment Centers
• Inpatient Treatment Centers
• Residential Treatment Centers

By Distribution Channel

• Hospital Pharmacies
• Medical Stores
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa